Search images on Google Product Monograph
Active Ingredients:
- tafasitamab, 200 MG/VIAL
DIN: 02518627
Dosage Form(s): POWDER FOR SOLUTION
Route(s) of Administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription
Company: INCYTE CORPORATION
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01F - (ATC, WHO)
- L01FX - (ATC, WHO)
- L01FX12 - TAFASITAMAB (WHO)